Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Basic HIV vaccine development.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

The highlight of the 2008 Conference on Retroviruses and Opportunistic Infections was a sober assessment of the HIV vaccine field by one of its pioneers. Desrosiers delivered a plenary session in which he called for refocusing our HIV vaccine effort. He suggested that none of the current vaccine candidates in human clinical trials stands a chance against HIV. Thus, we need to redirect our efforts to basic vaccine research. This call for a sea change in how we carry out HIV vaccine research has already had an impact, prompting a recent HIV vaccine summit in Bethesda, MD. This will likely herald a new era in HIV vaccine research, resulting in a redoubling of effort to uncover innovative new ways of making an HIV vaccine.

Original languageEnglish
Pages (from-to)7-8
Number of pages2
JournalTopics in HIV medicine : a publication of the International AIDS Society, USA
Volume16
Issue number1
StatePublished - Apr 1 2008
Externally publishedYes

Fingerprint

AIDS Vaccines
Vaccines
Research
Clinical Trials
HIV

ASJC Scopus subject areas

  • Medicine(all)

Cite this

@article{6385693470044d55a6cd355251ac93c2,
title = "Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Basic HIV vaccine development.",
abstract = "The highlight of the 2008 Conference on Retroviruses and Opportunistic Infections was a sober assessment of the HIV vaccine field by one of its pioneers. Desrosiers delivered a plenary session in which he called for refocusing our HIV vaccine effort. He suggested that none of the current vaccine candidates in human clinical trials stands a chance against HIV. Thus, we need to redirect our efforts to basic vaccine research. This call for a sea change in how we carry out HIV vaccine research has already had an impact, prompting a recent HIV vaccine summit in Bethesda, MD. This will likely herald a new era in HIV vaccine research, resulting in a redoubling of effort to uncover innovative new ways of making an HIV vaccine.",
author = "David Watkins",
year = "2008",
month = "4",
day = "1",
language = "English",
volume = "16",
pages = "7--8",
journal = "Topics in antiviral medicine",
issn = "2161-5853",
publisher = "International Antiviral Society",
number = "1",

}

TY - JOUR

T1 - Highlights of the 15th Conference on Retroviruses and Opportunistic Infections. Basic HIV vaccine development.

AU - Watkins, David

PY - 2008/4/1

Y1 - 2008/4/1

N2 - The highlight of the 2008 Conference on Retroviruses and Opportunistic Infections was a sober assessment of the HIV vaccine field by one of its pioneers. Desrosiers delivered a plenary session in which he called for refocusing our HIV vaccine effort. He suggested that none of the current vaccine candidates in human clinical trials stands a chance against HIV. Thus, we need to redirect our efforts to basic vaccine research. This call for a sea change in how we carry out HIV vaccine research has already had an impact, prompting a recent HIV vaccine summit in Bethesda, MD. This will likely herald a new era in HIV vaccine research, resulting in a redoubling of effort to uncover innovative new ways of making an HIV vaccine.

AB - The highlight of the 2008 Conference on Retroviruses and Opportunistic Infections was a sober assessment of the HIV vaccine field by one of its pioneers. Desrosiers delivered a plenary session in which he called for refocusing our HIV vaccine effort. He suggested that none of the current vaccine candidates in human clinical trials stands a chance against HIV. Thus, we need to redirect our efforts to basic vaccine research. This call for a sea change in how we carry out HIV vaccine research has already had an impact, prompting a recent HIV vaccine summit in Bethesda, MD. This will likely herald a new era in HIV vaccine research, resulting in a redoubling of effort to uncover innovative new ways of making an HIV vaccine.

UR - http://www.scopus.com/inward/record.url?scp=54049091269&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049091269&partnerID=8YFLogxK

M3 - Article

C2 - 18441377

AN - SCOPUS:54049091269

VL - 16

SP - 7

EP - 8

JO - Topics in antiviral medicine

JF - Topics in antiviral medicine

SN - 2161-5853

IS - 1

ER -